The MYH11 gene gives instructions for part of the muscle machinery that helps smooth muscle tighten in places like blood vessel walls, the gut, and the bladder. This gene helps your body keep these tissues working with the right amount of force. If it does not work properly, smooth muscle may not contract as it should. Some inherited variants in the MYH11 gene are linked to widening or tearing of the aorta, the body’s main artery, and sometimes to a small blood vessel near the heart staying open after birth.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which serve as the working parts of cells. Others mainly help determine when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To go into this topic in greater depth, you can find more in the LearnHub.
Overview
MYH11Gene function
What if the gene works
The MYH11 gene helps make a protein that lets smooth muscle cells contract. This supports steady movement and tone in blood vessels, the gut, and the bladder.
Risk
What if the gene does not work
Variants in the MYH11 gene can raise the chance of thoracic aortic aneurysm or dissection, sometimes with patent ductus arteriosus. Some variants can weaken bowel or bladder muscle, and variant severity can change features and when they appear.
Treatment
What does that mean for your treatment
No treatment, drug choice, or management approach specific to the MYH11 gene is currently established. Research is exploring the MYH11 gene mainly as a biomarker in aortic disease biology and, separately, in some leukemias.
Conditions associated with MYH11
Gene function
What if the gene works
If you carry the MYH11 gene, it helps the smooth muscles in blood vessels, the gut, the bladder, and the uterus tighten in a controlled way. These muscles work automatically, without conscious effort. This helps explain the MYH11 gene’s role in smooth muscle function throughout the body.
Its protein forms part of the motor machinery that lets smooth muscle cells pull on fibers called actin. This uses the cell’s energy source to create the force needed for contraction.
The MYH11 protein joins with partner proteins to build thick filaments, the core strands that make smooth muscle contract. This organized layout lets many cells shorten in a steady, coordinated way.
This gene supports the repeated tightening and relaxing of blood vessels and other hollow organs. That routine motion helps maintain vessel tone and move food, fluid, and urine along at an appropriate pace.
What is a variant?
Genetic variants are small differences in a gene’s DNA sequence. They are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Most variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Understanding how variants in the MYH11 gene affect smooth muscle starts with the protein itself: some changes make the myosin heavy chain fold poorly, bind actin less well, or assemble abnormally into contractile fibers. Other, more disruptive variants reduce how much working protein is made or sharply limit force generation. This spectrum from milder to more severe functional effects may help explain why aortic disease can appear later in some families and earlier or more extensively in others.
How variants are linked to conditions
Among MYH11 gene variants linked to conditions, the strongest evidence is for inherited thoracic aortic aneurysm and aortic dissection, and some families also have patent ductus arteriosus, a blood vessel near the heart that stays open after birth. In this setting, a disease-causing variant in the MYH11 gene can help confirm a hereditary aortic condition and explain why several relatives may need heart and blood vessel follow-up.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply contribute to natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the MYH11 gene itself. In families with a disease-causing MYH11 change, risk is mainly linked to the inherited variant, while blood pressure, smoking, and close medical follow-up can still matter for overall blood vessel health and early detection.
Inheritance of MYH11 variants
The inheritance pattern for MYH11-related conditions can differ depending on the specific condition and variant involved. In how MYH11 gene variants are inherited in families, the best-established pattern is autosomal dominant for thoracic aortic aneurysm and dissection, often with patent ductus arteriosus, which means a parent carrying the variant can pass it to each child with a 50% chance. Some rarer MYH11-related conditions have also been reported with autosomal recessive inheritance, meaning a child inherits one altered copy from each parent.
What does my MYH11 result mean for my family?
A harmful MYH11 variant is most often passed through families in a dominant pattern, so close relatives like parents, brothers, sisters, and children may also carry it. This can matter because some people with a MYH11-related result are at risk for enlargement or tearing of the body’s main artery. Family members may want to discuss whether genetic testing and heart and blood vessel checks are appropriate for them.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the MYH11 gene, a lab can analyze DNA from a blood sample, saliva, or a cheek swab. This MYH11 genetic testing looks for spelling changes or missing pieces, and the report may show no variant, a disease causing variant, or a change whose meaning is not yet clear.
When should I consider getting a genetic test?
Consider MYH11 genetic testing if you or close relatives have had an enlarged or torn aorta, especially at a younger age, or if this runs in the family. It can also be relevant when a family history includes a persistent blood vessel connection present at birth (patent ductus arteriosus) along with aortic disease.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they reveal varies by the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, shape how the body works. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug faster or slower, which can change how much of it reaches the bloodstream and tissues. This can influence how well a medicine works or how likely side effects are. These differences are common and are one part of why medication response varies alongside age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It studies links between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can help support more informed and individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the MYH11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so general questions about medicines, side effects, or new symptoms are best discussed with your doctor.
History
MYH11 entered medical genetics through two important lines of research rather than public attention. In the 1990s, cytogenetic studies linked changes involving the MYH11 gene to a subtype of acute myeloid leukemia, helping doctors connect chromosome findings with a specific cancer pattern. From these first observations, research expanded steadily. In the early 2000s, inherited variants in the MYH11 gene were also identified in some families with thoracic aortic aneurysm and aortic dissection, which widened its place in cardiovascular genetics. These discoveries showed that one gene could appear in very different areas of medicine depending on the type of genetic change involved. Over time, descriptions became more precise, and MYH11 became a recognized part of both leukemia and inherited aortic disease research.